@article{oai:nagasaki-u.repo.nii.ac.jp:00001555,
 author = {Yamasaki, Makiko and Abe, Shuhei and Miura, Kiyonori and Masuzaki, Hideaki},
 issue = {2},
 journal = {Acta medica Nagasakiensia},
 month = {Jan},
 note = {Aim: Self-sampling devices for oncogenic human papillomavirus (HPV) testing may be useful for improving participation in 
cervical cancer screening. The aim of this study was to investigate the effects of HPV self-sampling devices for non-attenders, 
who have not participated in regular cervical cancer screening. Methods: To determine whether HPV self-sampling devices improve participation in cervical cancer screening on a remote island, non-attenders aged 20?49 years were included in this study. Participation was defined as returning a self-sampling device and/or participating in a conventional cytology-based cervical cancer screening. From April 2014 to May 2015, written informed consent for participation in this study was obtained from 249 of 2,986 non-attenders in the Goto Islands and randomly assigned to the “re-call” group (n=124) or the self-sampling group (n=125). Results: The participation (by returning the HPV self-sampling device and/or attending a cervical cancer screening) rate was 12.1% (n = 15) in the “re-call” group and 76.0% (n = 95) in the self-sampling group. Only 50% of HPV-positive women (n=5) underwent cytological testing, and abnormal cytological findings were detected in two cases. For these two patients with abnormal cytology, carcinoma in situ was detected and treated. 
Conclusions: Offering HPV self-sampling devices may improve participation in cervical cancer screening on remote islands 
in Japan., Acta medica Nagasakiensia, 62(2), pp.55-61; 2019},
 pages = {55--61},
 title = {The effect of self-sampled HPV testing on participation in cervical cancer screening on a remote island},
 volume = {62},
 year = {2019}
}